We Absolutely Do Not Need an FDA for AI.

The article focuses on the challenges and debates surrounding the governance of artificial intelligence (AI), particularly in the context of OpenAI's corporate structure and recent leadership changes. Topics include the divergent opinions among AI experts on the significance of AI; the need for regulation; and the potential risks associated with government intervention, with the author arguing against the establishment of an Food and Drug Administration (FDA)-like agency for AI oversight.